Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.05
-0.13
(-0.36%)
After-Hours: 05:10
Indivior Pharmaceuticals Total Return Level : 37.63 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 37.63 |
| August 21, 2026 | 38.35 |
| August 20, 2026 | 39.30 |
| August 19, 2026 | 40.61 |
| August 18, 2026 | 41.01 |
| August 17, 2026 | 40.65 |
| August 14, 2026 | 40.58 |
| August 13, 2026 | 39.75 |
| August 12, 2026 | 40.28 |
| August 11, 2026 | 39.97 |
| August 10, 2026 | 40.01 |
| August 07, 2026 | 40.38 |
| August 06, 2026 | 40.22 |
| August 05, 2026 | 40.28 |
| August 04, 2026 | 37.96 |
| August 03, 2026 | 38.87 |
| July 31, 2026 | 41.62 |
| July 30, 2026 | 41.83 |
| July 29, 2026 | 41.71 |
| July 28, 2026 | 42.63 |
| July 27, 2026 | 41.64 |
| July 24, 2026 | 42.15 |
| July 23, 2026 | 42.14 |
| July 22, 2026 | 42.07 |
| July 21, 2026 | 42.07 |
| Date | Value |
|---|---|
| July 20, 2026 | 40.69 |
| July 17, 2026 | 42.17 |
| July 16, 2026 | 42.22 |
| July 15, 2026 | 42.57 |
| July 14, 2026 | 41.84 |
| July 13, 2026 | 41.82 |
| July 10, 2026 | 42.13 |
| July 09, 2026 | 42.96 |
| July 08, 2026 | 42.53 |
| July 07, 2026 | 42.47 |
| July 06, 2026 | 41.59 |
| July 02, 2026 | 41.40 |
| July 01, 2026 | 41.87 |
| June 30, 2026 | 42.68 |
| June 29, 2026 | 42.92 |
| June 26, 2026 | 43.51 |
| June 25, 2026 | 42.95 |
| June 24, 2026 | 43.13 |
| June 23, 2026 | 41.56 |
| June 22, 2026 | 39.86 |
| June 18, 2026 | 39.84 |
| June 17, 2026 | 39.45 |
| June 16, 2026 | 39.54 |
| June 15, 2026 | 39.94 |
| June 12, 2026 | 40.02 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Supernus Pharmaceuticals, Inc. | 45.11 |
| Liquidia Corp. | 70.27 |
| Corcept Therapeutics, Inc. | 123.24 |
| Amneal Pharmaceuticals, Inc. | 17.78 |
| Prestige Consumer Healthcare, Inc. | 52.02 |